Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1553 of 5804
-
Can a smartphone app help cancer patients kick the habit?
Disease control OngoingThis phase III trial compares the Quit2Heal smoking cessation smartphone application (app) to the QuitGuide app in helping cancer patients quit smoking. Both apps provide tools to cope with urges to smoke, step-by-step guides for quitting smoking, help in planning for quitting an…
Phase: PHASE3 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 26, 2026 18:12 UTC
-
Could an antidepressant help stroke survivors regain speech?
Symptom relief Recruiting nowIn this project, the investigators will investigate the effects of a selective serotonin reuptake inhibitor (SSRI), escitalopram, on augmenting language therapy effectiveness, as measured by naming untrained pictures and describing pictures, in individuals with aphasia in the acu…
Phase: PHASE2 • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
New heart valve device offers hope for High-Risk patients
Disease control OngoingInterventional study to evaluate the safety and efficacy of the Medtronic CoreValve™ Evolut™ PRO System when used by China implanting centers in Chinese patients with severe symptomatic aortic stenosis (AS) who are at high risk for Surgical Aortic Valve Replacement (SAVR).
Phase: NA • Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Could a weekly shot delay diabetes in cystic fibrosis? new trial launches
Disease control Recruiting nowDiabetes is a major co-morbidity in pancreatic insufficient cystic fibrosis (PI-CF) and associated with worse outcomes. While reduced β-cell mass contributes to the insulin secretory defects that characterizes cystic fibrosis-related diabetes (CFRD), other modifiable determinants…
Phase: PHASE2 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Brain exercises may boost aging minds: new study tests computerized training
Disease control CompletedThis study is a validation study to evaluate efficacy of a neuroplasticity-based, computerized cognitive training program INHANCE (Improving Neurological Health in Aging via Neuroplasticity-based Computerized Exercise) to improve neurological and neuropsychological health in olde…
Phase: NA • Sponsor: Posit Science Corporation • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Genetic detective study aims to solve medical mysteries for 1,000 undiagnosed patients
Knowledge-focused Recruiting nowThe primary purpose of this study is to discover new disease genes for rare Mendelian disorders and its secondary purpose include diagnosing people with rare genetic disorders that have not been previously diagnosed through conventional clinical means, learning more about the pat…
Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
New obesity drug combo shows promise in early trial
Disease control CompletedThe study is looking at a new medicine to help people lose weight. In this study participants will either get semaglutide and NNC0165-1875 or semaglutide and a "dummy" medicine (placebo). Which treatment participants get is decided by chance. Participants will get 2 injections pe…
Phase: PHASE2 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New screening tool aims to spot suicide risk in kids with autism
Knowledge-focused CompletedBackground: Suicide is the second leading cause of death for young people ages 10-24 years. There is no gold standard for evaluating suicidal thoughts and behaviors in young people with autism spectrum disorder (ASD) or other neurodevelopmental disorders (NDD). Also, youth with …
Sponsor: National Institute of Mental Health (NIMH) • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
Lung cancer combo trial halted early: what we know
Disease control TerminatedThis study is designed to determine if combining consolidative radiation therapy (RT) using a hypofractionated regimen (hfRT) (2 fractions) for boosting the residual primary lung cancer with adjuvant anti-PD-L1 therapy concurrently is safe and will provide better tumor control lo…
Phase: PHASE1, PHASE2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Double-Drug attack on rheumatoid arthritis shows promise in new trial
Disease control OngoingAs stated by the European League Against Rheumatism (EULAR) and the Société Française de Rhumatologie (SFR), treatment of patients with rheumatoid arthritis (RA) should target sustained remission or at least low disease activity. However, despite significant advances based on var…
Phase: PHASE3 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
ICU survivors at risk of brittle bones: new trial tests One-Time fix
Disease control Recruiting nowThe Bone Zone trial is a prospective, multi-centre, double-blind, phase II, randomised controlled trial evaluating the effect of denosumab or zoledronic acid compared to placebo on change in bone mineral density over one year in women aged 50 years or older and men aged 70 years …
Phase: PHASE2 • Sponsor: Australian and New Zealand Intensive Care Research Centre • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Fewer trips to the hospital? new cervical cancer radiation trial aims to cut treatment time
Disease control OngoingThis study is a randomized controlled trial designed to compare hypofractionated whole pelvic radiotherapy with conventional radiotherapy in patients with cervical cancer undergoing concurrent chemoradiotherapy. Hypofractionated radiotherapy delivers a higher dose per treatment …
Phase: NA • Sponsor: Siriraj Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New drug crizanlizumab tested for safety in indian sickle cell patients
Disease control CompletedSickle cell disease (SCD) is a genetic blood disorder. Crizanlizumab is indicated to reduce the frequency of vaso-occlusive crises (VOCs) in patients with SCD aged 16 years and older. The purpose of this local Phase IV study was to evaluate the safety of crizanlizumab specifical…
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Can biktarvy help Late-Stage HIV patients catch up?
Disease control CompletedThe efficacy and safety of Biktarvy in Treatment-Naïve Late Presenters with HIV-1 Infection
Phase: PHASE4 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New implant offers hope for back pain sufferers
Disease control CompletedThis study is a prospective, randomized study comparing ReActiv8 Therapy to Optimal Medical Management (OMM).
Phase: NA • Sponsor: Mainstay Medical • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
HIIT bikes may boost brain power in breast cancer patients on chemo
Symptom relief Recruiting nowThe purpose of this research is to determine whether a 16-week high intensity interval training (HIIT) exercise program will improve brain health among women undergoing chemotherapy and also improve cardiovascular (heart) function. The names of the study interventions involved i…
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Can a simple score predict which kids with kawasaki disease need stronger treatment?
Knowledge-focused Recruiting nowKawasaki disease (KD) is currently the leading cause of acquired heart diseases in children in developed countries. Cardiac involvement is the main determinant of the long-term prognosis of these patients, as coronary aneurisms (CAAs) may lead to ischemic heart disease and even s…
Sponsor: Meyer Children's Hospital IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
New heart valve procedure shows promise for severe aortic stenosis
Disease control OngoingEvaluation of TAVR using the NAVITOR valve in a Global Investigation.
Phase: NA • Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Could a vibrating throat patch silence chronic cough?
Symptom relief Recruiting nowResearchers will test the effect of non-invasive vibrotactile stimulation of the larynx on symptom severity of unexplained chronic cough.
Phase: NA • Sponsor: University of Minnesota • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Pepper patch takes on Post-Surgery pain in major trial
Symptom relief CompletedThis is an interventional, Phase III, double-blind, randomized, controlled, parallel-group, multi-site, clinical trial to confirm the efficacy and safety of repeated topical application of Qutenza (capsaicin 8% topical system) versus low-dose capsaicin control (capsaicin 0.04% to…
Phase: PHASE3 • Sponsor: Averitas Pharma, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC